Abbasi, S. et al. 2024. A pilot study of activity of pembrolizumab and low dose chemotherapy in relapsed/refractory T-cell lymphoma: Jordanian experience. Acta Biomedica Atenei Parmensis. 95, 5 (Oct. 2024), e2024102. DOI:https://doi.org/10.23750/abm.v95i5.15559.